Managing Patent Attorney
(858) 587-2510 ext. 201
Ray has prosecuted over 100 US Patents in technologies ranging from medical devices and treatments - to - electronic monitoring of cells - to - DNA and RNA analytic methods - to - protection against electromagnetic radiation and more. His patent practice includes patent counseling; preparation and prosecution of patent applications; patent porfolio management and audits; due diligence; freedom to operate analysis; non-infringement opinions; and patent litigation services.
Ray's trademark practice includes trademark counseling and registration; trademark oppositions, and trademark cancellations.
Ray is also an accomplished researcher. He is a contributing author on a number of peer-reviewed scientific publications in the field of immunology and drug discovery. Ray was formerly a researcher within the Department of Medicine at the University of California, San Diego (UCSD) and at a San Diego-based start-up biotechnology company.
Ray received a Bachelor of Science degree in Molecular Biology from the University of California, San Diego (UCSD) (1995) and a Juris Doctorate at the University of San Diego, School of Law (2002), where he was elected Vice President of the Science and Technology Law Society.
Bar & Admissions
- State of California
- United States Patent and Trademark Office (USPTO)
- US District Court, Southern District of California
- US District Court, Central District of California
- US Court of Appeals for the Federal Circuit (Washington, DC)
- US 8,344,742 - Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
- US 8,329,114 - Devices and methods for sampling biological fluids
- US 8,283,169 - Differential Gradient Separation of Cells
- US 8,142,444 - Circumcision clamp and surgical kit
- US 8,058,296 - Treatment and prevention of deleterious effects associated with alcohol consumption
- US 8,044,376 - Devices and methods for protection against exposure to electromagnetic radiation
- US 7,816,080 - Identifying organisms by detecting intronic nucleic acid or encoded proteins
- US 7,780,915 - Fecal sample test device and methods of use
- US 7,741,539 - Transformed plant cell expressing five mammalian proteins involved in sialylation and a protein involved in galactosylation
- US 7,741,028 - Methods of identifying genetic markers in the human cystic fibrosis transmembrane conductance regulator (CFTR) gene
- A B Cell Superantigen-induced Persistent 'Hole' in the B-1 Repertoire
G.J. Silverman, S. Cary, D. Dwyer, L. Luo, R. Wagenknecht and V.E. Curtiss.
J. Exp. Med., 2000 Jul 3;192(1):87-98.
- Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface
Cary SP, Lee J, Wagenknecht R, Silverman GJ
J. Immunol., 2000 May 1;164(9):4730-41
- A B-Cell Superantigen That Targets B-1 Lymphocytes"
Silverman GJ, Cary S, Graille M, Curtiss VE, Wagenknecht R, Luo L, Dwyer D, Goodyear C, Corper AL, Stura EA, Charbonnier JB
Curr Top Microbiol Immunol. 2000;252:251-63
- Improved two-dimensional gel electrophoresis representation of serum proteins using ProtoClearTM
Lollo BA, Harvey S, Liao J, Stevens AC, Wagenknecht R, Sayen R, Whaley J, Sajjadi FG.
Electrophoresis, 1999 Apr-May;20:854-9
- In Vivo Consequences of a B-Cell Superantigen Immunization”
Gregg J. Silverman, Jayakar Nayak, Raymond Wagenknecht, Klaus Warnatz.
Ann. N.Y. Acad. Sci., 1997 Apr 5;815:105-110